TD Cowen lowered the firm’s price target on Option Care Health (OPCH) to $27 from $30 and keeps a Hold rating on the shares. The firm updated its model following Q3 results as Stelara uncertainty suggests a more cautious 2026 outlook.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health’s Earnings Call Highlights Growth and Challenges
- Option Care Health price target lowered to $36 from $38 at Citizens JMP
- Option Care Health Reports Strong Q3 2025 Results
- Option Care Health: Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Option Care Health reports Q3 adjusted EPS 45c, consensus 43c